The Microbiome in Human Disease Symposium was held on October 3, 2018. Hosted by the Harvard Catalyst Reactor Program, the event drew more than 400 attendees.
Human microbiota, the collection of microorganisms living inside and on the surface of our bodies, have been associated with various aspects of numerous diseases. These associations include susceptibility, causation, complications, and even prevention. While the impact of translational microbiological research, most dramatically in the cure and prophylaxis of infectious diseases, has been extraordinary, the relationship of the microbiome to other disease states remains under investigated, as does the import of microbial ecology in normal and pathological states.
This symposium provided researchers with the opportunity to learn about current human microbiome research and promote a greater understanding of the role(s) microbiomes play in the manifestation and treatment of human disease in its broadest sense. Information about many of the microbiome-related cores and services from across the university and hospitals were highlighted.
(Slides approved for distribution are attached below)
Emily Balskus, PhD, Harvard University
Deciphering the Human Microbiota using Chemistry
Ashwin Ananthakrishnan, MBBS, MPH, Massachusetts General Hospital
The Predictive Role of the Microbiome in Inflammatory Bowel Diseases
Matthew Meyerson, MD, PhD, Dana-Farber Cancer Institute
The Colorectal Cancer Microbiome
Hera Vlamakis, PhD, Broad Institute
Microbe-Host Interactions in Inflammatory Bowel Diseases
Howard L. Weiner, MD, Brigham and Women’s Hospital
Relationship of the Microbiome to Oral Tolerance and Therapy of Multiple Sclerosis
C. Ronald Kahn, MD, Joslin Diabetes Center
Genes, Environment and Microbiome Interactions in the Development of Diabetes & Metabolic Syndrome